维普中文期刊产品整合服务
42篇 您的检索式:作者名="Pecherstorfer"
    题名 作者 年代 出处 被引量
1Re-current hypoglycemia and lactate acidosis in non- Hodgkin' s lymphoma 显示文摘Abrahamian H Pecherstorfer M Vesely M 1991Dtsch Med Wochenschr1991,116,38:1
2Serum bone sialopro- tein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma 显示文摘Woitge HW Pecherstorfer M Horn E 2001Br J Cancer2001,84,3:1
3Long-term safety of intravenous ibandronic acid for up to 4 years in metastatic breast cancer: an open-label trial 显示文摘Pecherstorfer M Rivkin S Body JJ 2006Clin Drug Investig2006,26,6:1
4Long term safety of intravenous ibandronate for up to 4 years in metastatic breast cancer: an open label trial 显示文摘Pecherstorfer M Rivkin S Body JJ 2006Clin Drug lnvestig2006,26,6:1
5Peritoneal-fat flap vesicovaginal fistula 显示文摘Pecherstorfer M 1964Geburtshilfe plastic surgery for closure of Frauenheilkd1964,24,:1
6Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer显示文摘Jean-Jacques Body Ingo J. Diel Richard Bell Martin Pecherstorfer Michail R. Lichinitser Alexander F. Lazarev Debu Tripathy Bengt Bergstr?m 2004Pain2004,,3:1
7Serum bone sialoprotein as a marker of tumor burden anti neoplastic bone involvement and as a prognostic factor in multiple mveloma显示文摘Woitge HW Pecherstorfer M Horn E 2001Br J Cancer2001,84,2:1
8Serum bone sialo- protein as a marker of turnout burden and neoplastic bone involve- ment and as a prognostic factor in multiple myeloma显示文摘Woitge HW Pecherstorfer M Horn E 2001Br J Cancer2001,84,3:1
9Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma显示文摘Woitge HW Pecherstorfer M Horn E 2001Br J Cancer2001,84,3:1
10RandomizedphaselI trial comparing different dose of the biphophonateI bandronate in the treatmerit of hypercal cemia of malignancy显示文摘Pecherstorfer M Herrmann Z Body JJ 1996J Clin Oncol1996,14,3:1
11Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma 显示文摘WOITGE H W PECHERSTORFER M HORN E 2001Cancer2001,84,3:1
12Rapid administration of ibandr-onatedoes not affect renal functioning: evidence from clinical studies in metastatic bone disease and hypercalcaemia of malignancy 显示文摘Pecherstorfer M Diel IJ 2004Support Care Cancer2004,12,12:1
13Long-term safety of intravenous ibandronate for up to 4 years in metastatic breast cancer:an open-label trial显示文摘Pecherstorfer M Rivkin S Body J J 2006Clin Drug Investig2006,26,6:1
14Efficacy and safety of bandronate in the treatment of hypercalcemia of malignancy:a randomized multicentric comparison to pamidronate显示文摘PECHERSTORFER M STEINHAUER EU RIZZOLI R 2003Support Care Cancer2003,11,8:1
15Comparative tolera- bility of drug therapies for hypercalcaemia of malignancy 显示文摘Zojer N Keck AV Pecherstorfer M 1999Drug Saf1999,21,5:1
16Efficacy and safety of ibandronate in the treatment of hypercalcemia of malignancy:a randomized multicentric comparison to pamidronate显示文摘Pecherstorfer M Steunhauer EU Rizzoji R 2003Cancer2003,11,8:1
17Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy显示文摘 Sundal E Pecherstorfer M 1995Cancer1995,76,11:1
18Efficacy and safety of ibandronate in the treatment of hypercalcemia of malignancy: a randomized multicentric comparison to pamidronateo显示文摘PECHERSTORFER M STEINHAUER E U RIZZOLI R 2003Support Care Cancer2003,11,8:1
19Novel serum markers of bone resorption:clinical assessment and comparison with established urinary indicts显示文摘Woitge HW Pecherstorfer M Li y 1999J Bone Miner Res1999,14,:1
20Long-term safety of in- travenous ibandronic acid for up to 4 years in metastatic breast cancer: an open-label trial 显示文摘Pecherstorfer M Rivkin S Body JJ 2006Clin Drug Inves2006,26,6:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费